DT
HealthMore in Health→
The Next Shot: How GLP-1 Research Is Rewriting the Future of Weight Loss Medicine
With one in eight American adults now taking GLP-1 medications like Ozempic and Wegovy, researchers at Georgia State University have uncovered why patients regain weight after stopping treatment — and a potential combination therapy that could solve the problem by targeting the brain's stress response system.
Key Takeaways
- One in eight U.S. adults now takes GLP-1 medications like Ozempic or Wegovy for weight management
- GLP-1 drugs activate the brain's stress response system, elevating cortisol and causing muscle loss
DE
DT Editorial Team··6 min read·via medicalxpress.com